Uveal Melanoma
📧 Sign up to get email alerts when something new happens for Uveal Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma [Phase 2]
Phase 2 clinical trial evaluating cemiplimab plus ziv-aflibercept for metastatic uveal melanoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the safety and efficacy of IOV-3001 in adults with advanced melanoma who will receive lifileucel; t…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma [Phase 1, Phase 2]
This clinical trial update describes the ongoing Phase 1/2 study of NBM-BMX in metastatic uveal melanoma, including safety, efficacy, and ph…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Tebentafusp-tebn With LDT in Metastatic UM [Phase 1, Phase 2]
Phase 1/Phase 2 trial of tebentafusp-tebn with LDT in metastatic uveal melanoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME) [Phase 2]
This clinical trial update reports on a Phase 2 study evaluating pembrolizumab in combination with lenvatinib for efficacy and safety in pat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
This is a screening study by TScan Therapeutics to collect samples for tumor-associated antigens, HLA typing, and HLA loss of heterozygosity…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit [Phase 1]
Phase 1 study evaluating NN3201, a c-Kit targeted antibody-drug conjugate, in advanced and/or metastatic solid tumors expressing c-Kit; curr…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases [Phase 1]
Phase 1 trial evaluating hepatic arterial infusion of autologous tumor-infiltrating lymphocytes in patients with metastatic melanoma to the …
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR) [NA]
The document reports the completion of a study to develop a patient communication tool (HECTOR) for discussing cancer treatment resistance, …
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma [Phase 1]
A Phase 1 clinical trial is evaluating locoregional or systemic administration of autologous tumor-infiltrating lymphocytes in patients with…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: PHP and Immunotherapy in Metastasized UM [Phase 1, Phase 2]
Phase 1/2 trial evaluating PHP in combination with immunotherapy for metastatic uveal melanoma; the study is currently active but not recrui…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME) [NA]
This entry describes the SALOME clinical trial studying follow-up of patients with uveal melanoma to adapt to relapse risk; the study is cur…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: A Prospective Natural History Study in Uveal Melanoma
This clinical trial update describes a prospective natural history study in patients with uveal melanoma, currently active and not recruitin…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma [Phase 1]
A Phase 1, single-arm trial evaluating tumor-treating fields in combination with nivolumab and ipilimumab for metastatic uveal melanoma has …
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of APG-115 alone or with pembrolizumab in metastatic melanoma and other advanced solid tumors; the trial is currently active…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N) [Phase 1]
ClinicalTrials.gov entry updates the Phase 1 study of C7R-GD2.CART cells for relapsed or refractory GD2-positive cancers, including neurobla…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas [Phase 1, Phase 2]
A Phase I/II clinical trial evaluating DYP688 in patients with metastatic uveal melanoma and other GNAQ/11-mutant melanomas; the study is cu…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma [Phase 2]
Phase 2 clinical trial update for tebentafusp in molecularly relapsed melanoma shows an active but not recruiting study targeting both cutan…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Adding IL-2 to Tebentafusp to Eradicate Cancer Progression [Phase 1, Phase 2]
Announced clinical trial evaluating adding interleukin-2 to tebentafusp to eradicate cancer progression in uveal melanoma, including metasta…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma [Phase 2]
A Phase 2 clinical trial studying adoptive transfer of tumor-infiltrating lymphocytes for metastatic uveal melanoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Adjuvant Quisinostat in High-Risk Uveal Melanoma [Phase 2]
This document reports a Phase 2 adjuvant trial of quisinostat in high-risk uveal melanoma, which is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Adjuvant Melatonin for Uveal Melanoma [Phase 3]
A Phase 3 clinical trial evaluating adjuvant melatonin for uveal melanoma is currently recruiting.
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: PHP in Combination With IPI1/NIVO3 Compared to IPI3/NIVO1 Only in Patients With Uveal Melanoma Liver Metastases [Phase 3]
Phase 3 trial evaluating PHP in combination with ipilimumab and nivolumab versus ipilimumab and nivolumab alone in patients with uveal melan…
-
CLINICAL_TRIALS research · 2014-12-03Clinical Trial Update: A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma [Phase 2]
This clinical trial update describes a Phase 2 study of sorafenib in chemonaive metastatic uveal melanoma. The current status is listed as U…
-
CLINICAL_TRIALS research · 2011-09-28Clinical Trial Update: Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma
This entry notes a recruiting clinical trial investigating the effectiveness of serum biomarkers for diagnosing uveal melanoma, including me…